B-cell lymphoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  

B-cell lymphoma
Feb 13, 2025, 06:52 | Drugs
FDA Approved Brentuximab Vedotin Combo for Relapsed/Refractory LBCL
On February 11, 2025, the FDA approved the use of brentuximab vedotin (Adcetris, Seagen Inc.,…
Feb 12, 2025, 06:48 | Blog
Ahmed Kotb: BSH 2024 Guideline on Large B-cell Lymphoma
Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company,…
Feb 3, 2025, 10:33 | Science
A novel CAR T cell therapy for people with large B-cell lymphoma by Jae Park et al. - MSK Department of Medicine
MSK Department of Medicine shared a post on X about a recent paper by Jae…
Feb 1, 2025, 14:47 | Insight
MD Anderson Cancer Center's Research Highlights
Featuring novel treatment strategies for lymphomas and kidney cancers, insights into inflammatory pain, and promising…
Nov 20, 2024, 19:12 | Insight
Ajay Major: Golcadomide and R-CHOP as first line for LBCL by Arnaud Amzallag et al.
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…
Nov 3, 2024, 17:05 | Insight
Vincent Rajkumar: Survival improvement in patients with HIV associated B cell lymphoma that adopted the Medicaid expansion of ACA
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post…
Nov 2, 2024, 12:00 | Blog
The Latest Advances and Optimal Strategies for Peripheral T-Cell Lymphoma Treatment - Media Medic
Media Medic posted on LinkedIn: "The 5th Tianjin International Lymphoma Academic Conference, serving as an…
Oct 23, 2024, 10:00 | Insight
MD Anderson Research Highlights
Featuring novel targets for breast cancer, epigenetic strategies to improve immune responses, a treatment for…
Oct 7, 2024, 11:49 | Blog
Mohamed Benlazar: The future of immunotherapy for diffuse large B-cell lymphoma
Mohamed Benlazar, Professor of Hematology at Sidi Bel Abbès University Hospital, shared a post on…
Sep 30, 2024, 15:06 | Blog
Chul Kim: Aaron Goodman on CAR T cells for B cell lymphoma at ET24
Chul Kim posted on X: "Great talk by Aaron Goodman on CAR T cells for…
Sep 26, 2024, 12:10 | Celebrities
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
Jeff Bridges, the Academy Award-winning actor best known for his roles in "The Big Lebowski"…
Sep 11, 2024, 17:29 | Blog
Paper Collection on the topic "Hodgkin's Lymphomas and B-cell Lymphoma" in FBL
Cyndi Chua, Commissioning Editor at Frontiers in Bioscience-Landmark, shared a post on X: "Paper Collection…
Aug 24, 2024, 06:23 | Insight
Hematology Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma
Raul Cordoba shared on X: “Hematology Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37…
Jul 26, 2024, 08:01 | Blog
July 2024 Tip Sheet of Sylvester Comprehensive Cancer Center
This month’s tip sheet from Sylvester Comprehensive Cancer Center at the University of Miami Miller…
Jul 21, 2024, 16:40 | Insight
Hung Trinh: FDA breakthrough designation for trial of cell-based therapy for high-risk lymphoma
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Jul 16, 2024, 23:11 | Blog
The role of TP53 and ctDNA kinetics in patients with R/R DLBCL
VJHemOnc (The Video Journal of Hematology and Hematological Oncology) shared a post on X: ''In…
Jul 12, 2024, 07:47 | Blog
Potential breakthrough for patients with relapsed or refractory large B-cell lymphoma - Parker Institute for Cancer Immunotherapy
Yan Leyfman, Co-Founder and Executive Director at MedNews Week,  shared a posted by Parker Institute…
Jun 27, 2024, 13:17 | Insight
Non-chemotherapy treatment regimen for aggressive B-cell lymphoma
Kimryn Rathmell shared on X: "Exciting news: NCI researchers and collaborators have developed a non-chemotherapy…
Jun 23, 2024, 14:07 | Blog
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Mark Roschewski, Senior Clinician in the Lymphoid Malignancies Branch at the National Cancer Institute, shared a…
Jun 11, 2024, 14:59 | Insight
Timos Papagatsias: EHA24 is expected to be one of the most exciting EHA conferences to-date!
Timos Papagatsias, CEO of LucidQuest shared a post on LinkedIn: “EHA24 is fast approaching and…
May 24, 2024, 09:10 | Stories
William Floyd High School Unites in Honor of Rayna’s Fight Against Cancer - St. Baldrick’s Foundation
St. Baldrick’s Foundation shared a post on LinkedIn: "Cara is a long-time volunteer who lost…
May 22, 2024, 06:44 | Insight
Nausheen Ahmed: A deeper look at social determinants of health and CAR-T
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
Apr 21, 2024, 18:36 | Blog
Talha Badar: Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity
Talha Badar, Assistant Professor of Oncology at Mayo Clinic, shared a post on X: “Real-World…
Apr 17, 2024, 11:47 | Blog
The collaboration that ultimately led to a phase II clinical trial at Massachusetts General Hospital, where Serena found her miracle - St. Baldrick's Foundation
St. Baldrick's Foundation shared a post on LinkedIn: "David DiCillo (Dave) and Michael Tucker (Mike) are…
Feb 12, 2024, 01:17 | Insight
Aaron Goodman: Sorting out High Grade B-cell Lymphomas using morphology and FISH!
Aaron Goodman shared a post on X/Twitter: “Sorting out High Grade B-cell Lymphomas using morphology and…
Jan 5, 2024, 11:32 | Insight
Qiang Pan-Hammarström: We developed a new 24-gene expression score to identify high risk for developing refractory/relapsed lymphoma
Qiang Pan-Hammarström, Professor of Clinical Immunology and member of Nobel Assembly at the Karolinska Institute,…
Oct 12, 2023, 15:38 | Insight
NCCN published the first Chemotherapy Order Templates for pediatric cancer. - National Comprehensive Cancer Network (NCCN)
National Comprehensive Cancer Network (NCCN) shared on LinkedIn: “NCCN published the first Chemotherapy Order Templates…
Sep 21, 2023, 18:12 | Insight
Fiona Hamilton Marshall: These are hopeful findings for patients with relapsed/refractory diffuse large B-cell lymphomawho may not have a durable response to existing therapies.
Sep 20, 2023, 17:13 | Insight
Jeff Ryckman: How many patients make it to CAR-T without ever seeing radiotherapy?
Jeff Ryckman, Radiation Oncologist and Assistant Professor at West Virginia University shared a post by…
Sep 14, 2023, 02:57 | Insight
Michael Dickinson: In our article, we report on the development of rapid CART - YTB323, also known as rapcabtagene autoleucel.
Michael Dickinson, Haematologist at Peter MacCallum Cancer Centre, recently shared on LinkedIn: "RAPID CAR-T! Autologous…
All: 30 Posts: 1 - 100
Special Coverage